Original
PET/TC con18F-FDG en la recurrencia del cáncer de ovario: Impacto clínico, correlación con TC con contraste iv y CA-125, y valor pronóstico
18F-FDG PET/CT in ovarian cancer recurrence: Clinical impact, correlation with ceCT and CA-125, and prognostic value
Leído
1135
Vecesse ha leído el artículo
430
Total PDF
705
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 7 | 2 | 2 | 4 |
| 2025 4 | 1 | 2 | 3 |
| 2025 3 | 1 | 2 | 3 |
| 2024 11 | 1 | 2 | 3 |
| 2024 10 | 1 | 0 | 1 |
| 2024 9 | 6 | 0 | 6 |
| 2024 8 | 1 | 2 | 3 |
| 2024 6 | 2 | 1 | 3 |
| 2024 2 | 9 | 0 | 9 |
| 2024 1 | 5 | 0 | 5 |
| 2023 12 | 1 | 2 | 3 |
| 2023 11 | 2 | 2 | 4 |
| 2023 10 | 5 | 8 | 13 |
| 2023 7 | 1 | 2 | 3 |
| 2023 6 | 3 | 2 | 5 |
| 2023 4 | 0 | 2 | 2 |
| 2023 3 | 7 | 2 | 9 |
| 2022 1 | 1 | 0 | 1 |
| 2022 11 | 8 | 6 | 14 |
| 2022 10 | 4 | 7 | 11 |
| 2022 9 | 2 | 2 | 4 |
| 2022 7 | 1 | 0 | 1 |
| 2022 6 | 21 | 3 | 24 |
| 2022 4 | 1 | 2 | 3 |
| 2022 3 | 5 | 4 | 9 |
| 2022 2 | 1 | 2 | 3 |
| 2021 1 | 326 | 163 | 489 |
| 2021 12 | 141 | 87 | 228 |
| 2021 11 | 78 | 63 | 141 |
| 2021 10 | 2 | 0 | 2 |
| 2021 9 | 4 | 8 | 12 |
| 2021 8 | 26 | 12 | 38 |
| 2021 7 | 36 | 24 | 60 |
| 2021 6 | 0 | 4 | 4 |
| 2021 5 | 0 | 4 | 4 |
| 2021 4 | 0 | 8 | 8 |
Mostrar todo
